Nektar Therapeutics Is A Clinical Stage Biopharmaceutical Company Based In San Franciscocaliforniafounded In 1990The Company Focuses On Developing Novel Therapies That Modulate The Immune System To Address Autoimmune Disorderschronic Inflammatory Conditionsand Cancernektar Utilizes Advanced Polymer Conjugate Technologies And Has A Strong Emphasis On Drug Discovery And Development The Company Collaborates With Various Partnersincluding Bristol Myers Squibb And Astrazenecato Advance Its Therapeutic Pipelinenotable Investigational Therapies Include Rezpegaldesleukin For Autoimmune Diseasesnktr 255 For Hematologic Malignanciesand Nktr 0165 Targeting Inflammatory Bowel Diseasenektar Is Committed To Innovation In Immune Modulationpositioning Itself As A Significant Player In The Development Of Next Generation Therapeutics
No conferences found for this company.
| Company Name | Nektar Therapeutics Uk Ltd |
| Country |
United Kingdom
|
| Address | N/A |
| Telephone | N/A |
| N/A |
